Midgard Science

Axolabs

Kulmbach, Germany axolabs.com

From their website, Nov 2026

Work here? Claim this listing

About

Axolabs provides CRO and CDMO services for nucleic acid therapeutics, including oligonucleotides and RNA modalities. It works from sites in Petaluma, USA, and Berlin and supports projects from discovery and preclinical work through GMP manufacturing and clinical supply.

Services

  • In silico & bioinformatics

    Uses proprietary algorithms and sequence modeling to predict off-target interactions and support rational lead selection before benchwork begins.

    Assays & in vitro testing

  • Rational design & synthesis

    Performs chemical modification and solid-phase synthesis to improve oligonucleotide stability, reduce immunogenicity, and enable targeted delivery.

    Assays & in vitro testing

  • Preclinical screening

    Evaluates oligonucleotide libraries with automated synthesis, rapid purification, and multiplexed assays for efficacy, specificity, and safety.

    Assays & in vitro testing

  • Cell-based evaluations

    Uses in vitro platforms to assess on-target effects, cytotoxicity, and immunostimulation for early go/no-go decisions.

    Assays & in vitro testing

  • Advanced bioanalytics

    Applies proprietary PNA-HPLC, LC-MS/MS, and cytokine profiling to study kinetics, biodistribution, metabolism, and immune responses.

    Assays & in vitro testing

  • mRNA analytics

    Provides analytical characterization and bioanalytical support for mRNA therapeutics and vaccines, including critical quality attributes and pharmacology studies.

    Assays & in vitro testing

  • LNP Formulation Services

    Offers LNP formulation and characterization support for RNA therapeutics.

    Assays & in vitro testing

  • Early-stage oligonucleotide synthesis & lead optimisation

    Provides high-throughput early-stage synthesis for multiple RNA modalities using 96-well platforms and conjugation chemistry for ligand modifications.

  • Large-scale oligonucleotide manufacturing

    Delivers pilot to commercial scale manufacturing of oligonucleotides using Cytiva and AKB THESYS platforms.

    CDMO: development & manufacturing

  • cGMP production

    Provides dual-site cGMP manufacturing for oligonucleotide therapeutics for clinical and initial commercial supply.

    CDMO: development & manufacturing

  • GMP analytics & quality control

    Supports manufacturing with analytical QC and release testing using chromatographic and LC-MS methods.

    Assays & in vitro testing

  • Integrated technology transfer

    Coordinates transfer from discovery and pilot scale into scalable CDMO and GMP manufacturing workflows.

What to send
Synthesis request form (.xlsx) to be completed and sent to orders@axolabs.com

Capabilities

Assays and studies
Oligonucleotides · Bioanalysis · mRNA · Analytical development · LNP · LC-MS/MS · HPLC · Immunogenicity · RNA-Seq-based off-target analysis · PNA assay · Cell-based functional testing · Quantigene™
10 moreqPCR · RNA-Seq · xCELLigence® · Flow cytometry · PNA-HPLC · Cytokine profiling · uHPLC · AEX · RP · SEC
Scale and capacity
96-well platforms · Up to 300 mmol batch capacity · Milligram to kilogram batches · Dual-site cGMP manufacturing

Instruments and platforms

  • Cytiva OligoPilot™
  • Cytiva OligoProcess™
  • Asahi Kasei Bioprocess (AKB THESYS™)
  • AKB THESYS™ Synth100
  • AKB THESYS™ Synth1500
  • xCELLigence®

Modalities and species

Modalities
ADC · Oligonucleotide · mRNA · Vaccine · LNP / formulation

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GLPSelf-reported

    Scope: bioanalysis

  • GMPSelf-reported

    Scope: manufacturing and compliance

Company

Type
CRDMO
Founded
2000

Locations

Based in
Kulmbach, Germany
Sites
Petaluma, USA · Berlin, Germany · Kulmbach, Germany
Serves
global
BfR GLP site
Axolabs GmbH, Kulmbach, DE source

Contacts

Public records

GLP
In compliance · BfR source

Similar labs

Work here? Claim this listing